No Data
No Data
Earnings Week Ahead: TGT, COST, CRWD, AVGO, JD, PLUG, MRVL, and More
Earnings Preview: ARCT to Report Financial Results Post-market on March 06
BTIG Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $48
Press Release: Arcturus Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 6, 2025
BTIG Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Raises Target Price to $48
Arcturus Therapeutics Price Target Raised to $48 From $41 at BTIG
sooogod : How does this company have such a small Trade volume?
10baggerbamm OP sooogod : Bill Gates is backing this company. today's volume is extremely light I don't have an answer for it you see it it stands out like a sore thumb today there's just no buyers.. maybe they're waiting for like a $15.70 print 15.50 print I don't know but what I do know is out of nowhere is it reverses